Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP419462.RALEQuJQ5JGu2ZY71kCrvEL6YlbVev6CO6eNHZpFz5I24130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP419462.RALEQuJQ5JGu2ZY71kCrvEL6YlbVev6CO6eNHZpFz5I24130_assertion type Assertion NP419462.RALEQuJQ5JGu2ZY71kCrvEL6YlbVev6CO6eNHZpFz5I24130_head.
- NP419462.RALEQuJQ5JGu2ZY71kCrvEL6YlbVev6CO6eNHZpFz5I24130_assertion description "[Here we examined several human breast cancer cell lines having different levels of HER2/neu expression and found that apigenin exhibited potent growth-inhibitory activity in HER2/neu-overexpressing breast cancer cells but was much less effective for those cells expressing basal levels of HER2/neu.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP419462.RALEQuJQ5JGu2ZY71kCrvEL6YlbVev6CO6eNHZpFz5I24130_provenance.
- NP419462.RALEQuJQ5JGu2ZY71kCrvEL6YlbVev6CO6eNHZpFz5I24130_assertion evidence source_evidence_literature NP419462.RALEQuJQ5JGu2ZY71kCrvEL6YlbVev6CO6eNHZpFz5I24130_provenance.
- NP419462.RALEQuJQ5JGu2ZY71kCrvEL6YlbVev6CO6eNHZpFz5I24130_assertion SIO_000772 14602723 NP419462.RALEQuJQ5JGu2ZY71kCrvEL6YlbVev6CO6eNHZpFz5I24130_provenance.
- NP419462.RALEQuJQ5JGu2ZY71kCrvEL6YlbVev6CO6eNHZpFz5I24130_assertion wasDerivedFrom befree-2016 NP419462.RALEQuJQ5JGu2ZY71kCrvEL6YlbVev6CO6eNHZpFz5I24130_provenance.
- NP419462.RALEQuJQ5JGu2ZY71kCrvEL6YlbVev6CO6eNHZpFz5I24130_assertion wasGeneratedBy ECO_0000203 NP419462.RALEQuJQ5JGu2ZY71kCrvEL6YlbVev6CO6eNHZpFz5I24130_provenance.